Systemic inflammation is associated with a higher risk of cancer recurrence and mortality among colon cancer patients. Systemic inflammation promotes the growth and progression of existing micro-metastases and the development of new distant metastases. Reducing systemic inflammation may decrease the risk of developing recurrent and metastatic disease among colon cancer patients. Epidemiologic data suggests that physical activity after diagnosis of colon cancer reduces the risk of recurrence and mortality by 50%. Physical activity possesses potent anti-inflammatory properties. However, the extent to which physical activity can normalize the host microenvironment by interrupting the crosstalk between inflammation and the growth and progression of existing micro-metastases and the development of new distant metastases is not known. We hypothesize that physical activity mediates the relationship between inflammation and cancer recurrence and mortality.
Aim 1 will determine if physical activity mediates the relationship between plasma inflammatory markers and cancer recurrence and mortality among colon cancer patients. To complete this aim, we will utilize data from a recently-completed NCI-sponsored trial among 2,526 colon cancer patients.
Aim 2 will determine preliminary effect size estimates for two distinct doses of exercise to reduce plasma inflammatory markers among colon cancer patients. To complete this aim, we will utilize data from a recently-completed NCI-sponsored phase II trial that randomized 39 colon cancer patients to low-dose (150 min/wk) or high-dose (300 min/wk) moderate- intensity aerobic exercise or a usual care control group for six-months. The results from Aims 1 and 2 will guide the design and implementation of Aim 3, which will determine the efficacy of exercise to reduce plasma inflammatory markers among colon cancer patients. To complete this aim, we will conduct an adequately- powered prospective randomized trial among colon cancer patients. This research and training plan will: 1) provide the advanced transdisciplinary training necessary to accelerate the translation of epidemiologic discoveries into efficacious individual and population level interventions; 2) position the applicant to emerge as an international leader in the field of energy balance and cancer outcomes research, and; 3) validate a translational platform on which to examine other biologic pathways to be funded through future research project grant programs (R01s). Understanding how physical activity may alter inflammation to favorably influence disease outcomes among colon cancer patients offers unique insight into colon cancer biology and provides new paradigms in cancer therapy by optimizing treatment strategies and identifying additional therapeutic targets. This research aligns with an NCI key priority area to elucidate the molecular basis through which exercise may influence cancer outcomes, towards the goal of optimizing exercise prescription to maximize patient outcomes.

Public Health Relevance

Clinical and preclinical observations suggest that systemic inflammation increases the risk of cancer recurrence and mortality among colon cancer patients. Exercise possesses anti-inflammatory properties, but the extent to which exercise mediates the relationship between inflammation and cancer recurrence and mortality is unknown, and the efficacy for exercise to lower inflammation among colon cancer patients is also unknown. This carefully designed series of specific aims will provide insight on the potential mechanisms through which exercise may exert its anti-cancer effects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Career Transition Award (K99)
Project #
5K99CA218603-02
Application #
9525602
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Radaev, Sergey
Project Start
2017-07-15
Project End
2019-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
Brown, Justin C; Damjanov, Nevena; Courneya, Kerry S et al. (2018) A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivors. Psychooncology 27:1221-1228
Igwebuike, Lotachukwu T; Zhang, Xiaochen; Brown, Justin C et al. (2018) Applying pre-participation exercise screening to breast cancer survivors: a cross-sectional study. Support Care Cancer 26:1825-1831
Brown, Justin C; Yung, Rachel L; Gobbie-Hurder, Anita et al. (2018) Randomized trial of a clinic-based weight loss intervention in cancer survivors. J Cancer Surviv 12:186-195
Brown, Justin C; Caan, Bette J; Meyerhardt, Jeffrey A et al. (2018) The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: a population-based cohort study (C-SCANS). J Cachexia Sarcopenia Muscle 9:664-672
Brown, Justin C; Harhay, Michael O; Harhay, Meera N (2018) Self-reported major mobility disability and mortality among cancer survivors. J Geriatr Oncol 9:459-463
Brown, Justin C; Rickels, Michael R; Troxel, Andrea B et al. (2018) Dose-response effects of exercise on insulin among colon cancer survivors. Endocr Relat Cancer 25:11-19
Brown, Justin C; Ligibel, Jennifer A (2017) The Role of Physical Activity in Oncology Care. J Natl Cancer Inst Monogr 2017: